Filter Results:
(298)
Show Results For
- All HBS Web
(298)
- News (58)
- Research (196)
- Multimedia (6)
- Faculty Publications (123)
Show Results For
- All HBS Web
(298)
- News (58)
- Research (196)
- Multimedia (6)
- Faculty Publications (123)
- January 2006 (Revised April 2007)
- Case
General Electric Healthcare, 2006
By: Tarun Khanna and Elizabeth Raabe
In January 2006, Joe Hogan, head of General Electric (GE) Healthcare Technologies, prepared to step into William Castell's shoes as CEO of GE Healthcare, the world's leading manufacturer of diagnostic imaging equipment. In 2004, former CEO Jeff Immelt acquired Amersham... View Details
Keywords: Corporate Entrepreneurship; Cost vs Benefits; Growth and Development Strategy; Mergers and Acquisitions; Machinery and Machining; Global Range; Multinational Firms and Management; Product Design; Technological Innovation; Expansion; Value Creation; Business Subsidiaries; Health Industry; Medical Devices and Supplies Industry
Khanna, Tarun, and Elizabeth Raabe. "General Electric Healthcare, 2006." Harvard Business School Case 706-478, January 2006. (Revised April 2007.)
- 06 Jun 2018
- Video
Tarran Pierfelice, Blavatnik Fellow 2018-2019
- September 2014
- Case
Radiometer, 2013
By: John R. Wells and Galen Danskin
In 2013, Radiometer continued to lead the world in blood gas analysis equipment and accessories, selling direct and through distributors to hospital central laboratories, point-of-care locations, and non-hospital medical locations. Founded in 1935 and based in Denmark,... View Details
Keywords: Medical Devices; Medical Equipment ＆ Devices; Mergers ＆ Acquisitions; Strategic Analysis; Strategic Change; Family Business; Strategy; Mergers and Acquisitions; Medical Devices and Supplies Industry; Denmark; United States
Wells, John R., and Galen Danskin. "Radiometer, 2013." Harvard Business School Case 715-410, September 2014.
- September 2010 (Revised November 2011)
- Case
Salud Digna: Successfully Competing with For-Profit Organizations
By: Allen S. Grossman and Regina Garcia-Cuellar
Hugo Moreno, CEO of Salud Digna, was considering his growth options for the next three years. Would becoming a for-profit with access to greater capital be the best strategy or would this cause the organization to lose its social mission? Salud Digna provided... View Details
Keywords: For-Profit Firms; Health Testing and Trials; Growth and Development Strategy; Corporate Social Responsibility and Impact; Mission and Purpose; Nonprofit Organizations; Health Industry; Mexico
Grossman, Allen S., and Regina Garcia-Cuellar. "Salud Digna: Successfully Competing with For-Profit Organizations." Harvard Business School Case 311-051, September 2010. (Revised November 2011.)
- 27 Jan 2016
- News
Harvard Business School Launches Precision Trials Challenge
- Research Summary
Customer-Centric Marketing Strategy
By: Rohit Deshpande
Rohit Deshpandé's research program focuses on Customer-Centricity. A stream of projects examines the interaction between corporate and national culture as they influence the development and implementation of global marketing strategies in high performance firms. This... View Details
- October 2012
- Supplement
Aqua Bounty Courseware
By: Lucy White and Steve Burn-Murdoch
Valuation of a pre-revenue biotech company at IPO using probability trees and real option techniques. Company is based in Massachusetts and lists in London on AIM. Products are genetically-modified fast-growing salmon for fish farmers and disease-prevention drugs and... View Details
- 05 Apr 2016
- News
Our blood, ourselves
- 11 May 2011
- News
A New Era of Entrepreneurship
- September 2012 (Revised January 2014)
- Case
Aqua Bounty
By: Lucy White and Stephen Burn-Murdoch
Valuation of a pre-revenue biotech company at IPO using probability trees and real option techniques. Company is based in Massachusetts and lists in London on AIM. Products are genetically-modified fast-growing salmon for fish farmers and disease-prevention drugs and... View Details
Keywords: IPO; Valuation; Real Options; Decision Tree; Biotech; Genetically Modified; Salmon; Entrepreneurship; Finance; Agriculture and Agribusiness Industry; Biotechnology Industry; North and Central America; Europe; South America
White, Lucy, and Stephen Burn-Murdoch. "Aqua Bounty." Harvard Business School Case 213-047, September 2012. (Revised January 2014.)
- June 1996
- Case
Becton Dickinson: Managing the Global Enterprise, 1996
Becton Dickinson, a U.S.-based maker of medical and diagnostic devices, has been organized into a mixed structure of U.S.-based divisions and country/region organizations. In 1995, three businesses shifted to become worldwide divisions, forcing a reexamination of the... View Details
Keywords: Organizational Change and Adaptation; Business or Company Management; Multinational Firms and Management; Organizational Structure; Medical Devices and Supplies Industry; United States
Rosenzweig, Philip M. "Becton Dickinson: Managing the Global Enterprise, 1996." Harvard Business School Case 396-420, June 1996.
- April 1993 (Revised November 1994)
- Case
Chiron Corp.
Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
Keywords: Health Testing and Trials; Research and Development; Failure; Business Strategy; Joint Ventures; Strategic Planning; Opportunities; Product Development; Biotechnology Industry; California
Wheelwright, Steven C. "Chiron Corp." Harvard Business School Case 693-052, April 1993. (Revised November 1994.)
- October 2023 (Revised June 2024)
- Case
Revvity: A Symbol of Change
By: Satish Tadikonda and William Marks
After selling the PerkinElmer name and several ancillary business units, Prahlad Singh (CEO) and his team at the newly christened Revvity faced a challenge on how best to capitalize on the opportunities ahead for the business and emerge as winners within the Life... View Details
Tadikonda, Satish, and William Marks. "Revvity: A Symbol of Change." Harvard Business School Case 824-071, October 2023. (Revised June 2024.)
- December 2020 (Revised April 2021)
- Case
IBM Watson at MD Anderson Cancer Center
By: Shane Greenstein, Mel Martin and Sarkis Agaian
After discovering that their cancer diagnostic tool, designed to leverage the cloud computing power of IBM Watson, needed greater integration into the clinical processes at the MD Anderson Cancer Center, the development team had difficult choices to make. The Oncology... View Details
Keywords: Decision Making; Innovation Strategy; Knowledge Management; Knowledge Use and Leverage; Operations; Failure; Information Technology; Applications and Software; Health Care and Treatment; Product Development; Health Industry; Information Technology Industry; Technology Industry; United States; Houston; Texas
Greenstein, Shane, Mel Martin, and Sarkis Agaian. "IBM Watson at MD Anderson Cancer Center." Harvard Business School Case 621-022, December 2020. (Revised April 2021.)
- 11 Oct 2017
- Video
Empowering Women Through Personal Health Data
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details
Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- September 2003 (Revised October 2010)
- Case
A Pain in the Hip
By: Richard M.J. Bohmer
Describes in detail the process of diagnosing the cause of a sore hip in a young girl. Referred to the emergency room by her pediatrician, the child is subjected to a set of diagnostic tests over a two-day period, each designed to reduce the uncertainty surrounding the... View Details
Keywords: Production; Service Delivery; Service Operations; Performance Improvement; Health Industry
Bohmer, Richard M.J. "A Pain in the Hip." Harvard Business School Case 604-012, September 2003. (Revised October 2010.)
- 2022
- Report
Competitiveness Roadmap for India@100
By: Michael E. Porter and Christian H.M. Ketels
The Competitiveness Roadmap for India lays out policy principles to guide India's efforts to move towards middle-income and beyond over the next 25 years. It covers a discussion of appropriate outcome ambitions, the underlying development approach, specific policy... View Details
Porter, Michael E., and Christian H.M. Ketels. "Competitiveness Roadmap for India@100." Report, Institute for Competitiveness, India, September 2022.
- 2024
- Working Paper
Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how efforts on multiple fronts, including advocacy, training, and technological development, made ultrasound the second most commonly used diagnostic imaging technology (after X-rays). Specifically, we chronicle 1) ultrasound’s development... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-003, July 2019. (Revised May 2024.)
- June 2023 (Revised June 2023)
- Supplement
Roche: ESG and Access to Healthcare
By: George Serafeim
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George. "Roche: Innovation and Access to Healthcare." Harvard Business School Multimedia/Video Supplement 123-713, June 2023. (Revised June 2023.)